Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Actelion Pharmaceuticals introduces antibacterial compounds

Dec. 2, 2015

University of California, Oakland and WARF patent bacterial DNA gyrase inhibitors

Dec. 2, 2015

Valneva releases data from phase II study of prophylactic C. difficile vaccine candidate

Dec. 1, 2015

Roche reports anti-HBV agents

Dec. 1, 2015

FXR agonist EYP-001 shows activity against HBV replication

Nov. 30, 2015

Monoclonal antibody combination ASN-100 enters clinical study for S. aureus infection

Nov. 27, 2015

FDA approves Fluad seasonal influenza vaccine

Nov. 26, 2015

Summit releases promising findings from phase II trial of ridinilazole for C. difficile infection

Nov. 26, 2015

Kineta discloses antiviral RIG-I pathway modulators

Nov. 24, 2015

University of Adelaide to conduct phase I study of AmpliPhi's AB-SA01

Nov. 24, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...